<DOC>
	<DOCNO>NCT01131533</DOCNO>
	<brief_summary>The investigator investigate intraocular concentration pharmacokinetics erythropoietin single intravitreal injection human .</brief_summary>
	<brief_title>Intraocular Pharmacokinetics Erythropoietin After Single Intravitreal Injection Human</brief_title>
	<detailed_description>Intravitreal injection erythropoietin off-label use show beneficial eye diabetic macular edema.However , pharmacokinetic profile erythropoietin intravitreal injection human yet determine clearly . The purpose study determine intraocular pharmacokinetics erythropoietin single intravitreal injection prospective investigation .</detailed_description>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>diabetic macular edema fail respond recur previous macular focal laser photocoagulation intravitreal therapy , . visual acuity bad 40/200 snellen bisual acuity Eyes vitreomacular traction , active proliferative diabetic retinopathy , intraocular inflammation , uncontrolled intraocular pressure , cataract surgery within past six month , prior history vitreoretinal surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>